Molecules 2009, 14(10), 4166-4179; doi:10.3390/molecules14104166
Article

Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells

1email, 1email, 1email, 2email and 1,* email
Received: 1 September 2009; in revised form: 30 September 2009 / Accepted: 12 October 2009 / Published: 19 October 2009
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: A series of novel 2-phenylaminopyrimidine (PAP) derivatives structurally related to STI-571 were designed and synthesized. The abilities of these compounds to inhibit proliferation were tested in human chronic myeloid leukemia K562 cells. (E)-3-(2-bromophenyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]acrylamide(12d) was the most effective cell growth inhibitor and was 3-fold more potent than STI-571.
Keywords: 2-Phenylaminopyrimidine (PAP) derivative; STI-571; antiproliferative activity
PDF Full-text Download PDF Full-Text [381 KB, uploaded 18 June 2014 19:30 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Chang, S.; Yin, S.-L.; Wang, J.; Jing, Y.-K.; Dong, J.-H. Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells. Molecules 2009, 14, 4166-4179.

AMA Style

Chang S, Yin S-L, Wang J, Jing Y-K, Dong J-H. Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells. Molecules. 2009; 14(10):4166-4179.

Chicago/Turabian Style

Chang, Sheng; Yin, Shi-Liang; Wang, Jian; Jing, Yong-Kui; Dong, Jin-Hua. 2009. "Design and Synthesis of Novel 2-Phenylaminopyrimidine (PAP) Derivatives and Their Antiproliferative Effects in Human Chronic Myeloid Leukemia Cells." Molecules 14, no. 10: 4166-4179.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert